Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine Decroocq

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Neurocritical Care|March 19, 2025
Fatal Grade V Immune Effector Cell-Associated Neurotoxicity Syndrome After Chimeric Antigen Receptor T Cell Therapy Leading to Brain DeathMaxime Touron, Justine Decroocq, Sarah Benghanem
Obstetrics and Gynecology|July 9, 2014
Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancyJustine Decroocq, Louis Marcellin, Camille Le Ray, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2024
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case reportPierre Loap, Natacha Johnson, Rudy Birsen, et al.
Annals of Intensive Care|September 11, 2024
Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignanciesSwann Bredin, Justine Decroocq, Clément Devautour, et al.
Medecine Sciences : M/S|April 28, 2025
[Haematological malignancies in pregnancy]Justine Decroocq, Sangsong Wu, Mathilde Barrois, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2025
Exposure to the immune system during bridging radiotherapy for Car-T cellsPierre Loap, Justine Decroocq, Rudy Birsen, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2022
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosisClara Vigneron, Valentine Le Stang, Justine Decroocq, et al.
BMC Infectious Diseases|June 3, 2014
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemiaAnne-Marie Ronchetti, Benoit Henry, Katia Ambert-Balay, et al.
International Journal of Particle Therapy|August 2, 2024
Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma PatientsPierre Loap, Ludovic De Marzi, Justine Decroocq, et al.
Cancer Immunology Research|August 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid TumorsMaude Marchais, Luca Simula, Mélanie Phayanouvong, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Neurocritical Care|March 19, 2025
Fatal Grade V Immune Effector Cell-Associated Neurotoxicity Syndrome After Chimeric Antigen Receptor T Cell Therapy Leading to Brain DeathMaxime Touron, Justine Decroocq, Sarah Benghanem
Obstetrics and Gynecology|July 9, 2014
Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancyJustine Decroocq, Louis Marcellin, Camille Le Ray, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2024
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case reportPierre Loap, Natacha Johnson, Rudy Birsen, et al.
Annals of Intensive Care|September 11, 2024
Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignanciesSwann Bredin, Justine Decroocq, Clément Devautour, et al.
Medecine Sciences : M/S|April 28, 2025
[Haematological malignancies in pregnancy]Justine Decroocq, Sangsong Wu, Mathilde Barrois, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2025
Exposure to the immune system during bridging radiotherapy for Car-T cellsPierre Loap, Justine Decroocq, Rudy Birsen, et al.
Acta Oncologica (Stockholm, Sweden)|March 4, 2022
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosisClara Vigneron, Valentine Le Stang, Justine Decroocq, et al.
BMC Infectious Diseases|June 3, 2014
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemiaAnne-Marie Ronchetti, Benoit Henry, Katia Ambert-Balay, et al.
International Journal of Particle Therapy|August 2, 2024
Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma PatientsPierre Loap, Ludovic De Marzi, Justine Decroocq, et al.
Cancer Immunology Research|August 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid TumorsMaude Marchais, Luca Simula, Mélanie Phayanouvong, et al.
Pageof 5